In vitro cytotoxic and biochemical effects of 5-aza-2'-deoxycytidine
- PMID: 66984
In vitro cytotoxic and biochemical effects of 5-aza-2'-deoxycytidine
Abstract
The in vitro effect of 5-aza-2'-deoxycytidine (5-aza-CdR) on cytotoxicity and macromolecular synthesis in A(T1)C1-3 hamster fibrosarcoma cells was investigated. The in vitro concentrations that produce 50% cell kill for 5-aza-CdR were about 1.0 and 0.01 microng/ml for a 2- and 24-hr exposure, respectively. 5-aza-CdR inhibited the growth of the fibrosarcoma cells by 40% at a concentration of 0.05 microng/ml. Deoxycytidine, but not cytidine, was a potent antagonist of the cytotoxicity produced by 5-aza-CdR. At cytotoxic concentrations 5-aza-CdR did not appear to inhibit DNA, RNA, or protein synthesis during a 1-hr incubation as measured by the incorporation of radioactive thymidine, uridine,, or leucine into acid-insoluble material. At a concentration of 10 microng/ml, 5-aza-CdR stimulated the incorporation of radioactive thymidine into DNA by more than 50%. These results indicate that 5-aza-CdR is a very potent cytotoxic agent to tumor cells in vitro at concentrations that do not inhibit macromolecular synthesis.
Similar articles
-
Synergistic action of 5-aza-2'-deoxycytidine and 3-deazauridine on L1210 leukemic cells and EMT6 tumor cells.Cancer Res. 1979 Oct;39(10):3822-7. Cancer Res. 1979. PMID: 476619
-
In vitro biochemical and cytotoxicity studies with 1-beta-D-arabinofuranosylcytosine and 5-azacytidine in combination.Cancer Res. 1975 Oct;35(10):2853-7. Cancer Res. 1975. PMID: 50882
-
Depression of DNA synthesis in mouse spleen after treatment with 5-aza-2'-deoxycytidine.J Natl Cancer Inst. 1979 Oct;63(4):1035-9. J Natl Cancer Inst. 1979. PMID: 90150
-
Pharmacology of 5-Aza-2'-deoxycytidine (decitabine).Semin Hematol. 2005 Jul;42(3 Suppl 2):S9-16. doi: 10.1053/j.seminhematol.2005.05.002. Semin Hematol. 2005. PMID: 16015507 Review.
-
Biochemical aspects of heat sensitivity of tumour cells.Recent Results Cancer Res. 1977;(59):7-35. doi: 10.1007/978-3-642-81080-0_2. Recent Results Cancer Res. 1977. PMID: 331418 Review. No abstract available.
Cited by
-
Efficacy and safety of extended dosing schedules of CC-486 (oral azacitidine) in patients with lower-risk myelodysplastic syndromes.Leukemia. 2016 Apr;30(4):889-96. doi: 10.1038/leu.2015.265. Epub 2015 Oct 7. Leukemia. 2016. PMID: 26442612 Free PMC article. Clinical Trial.
-
Azacytidine treatment affects the methylation pattern of genomic and cell-free DNA in uveal melanoma cell lines.BMC Cancer. 2024 Oct 21;24(1):1299. doi: 10.1186/s12885-024-13037-4. BMC Cancer. 2024. PMID: 39434038 Free PMC article.
-
High cytidine deaminase expression in the liver provides sanctuary for cancer cells from decitabine treatment effects.Oncotarget. 2012 Oct;3(10):1137-45. doi: 10.18632/oncotarget.597. Oncotarget. 2012. PMID: 23087155 Free PMC article.
-
Meiotically stable natural epialleles of Sadhu, a novel Arabidopsis retroposon.PLoS Genet. 2006 Mar;2(3):e36. doi: 10.1371/journal.pgen.0020036. Epub 2006 Mar 17. PLoS Genet. 2006. PMID: 16552445 Free PMC article.
-
p53 independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia.Leukemia. 2011 Nov;25(11):1739-50. doi: 10.1038/leu.2011.159. Epub 2011 Jun 24. Leukemia. 2011. PMID: 21701495 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources